See more : Master Ad Public Company Limited (MACO.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Zymergen Inc. (ZY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zymergen Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- PT Sarana Menara Nusantara Tbk. (SMNUF) Income Statement Analysis – Financial Results
- Chesser Resources Limited (CESSF) Income Statement Analysis – Financial Results
- Wells Fargo & Company (WFC-PQ) Income Statement Analysis – Financial Results
- Kellton Tech Solutions Limited (KELLTONTEC.NS) Income Statement Analysis – Financial Results
- Lvpai Group Limited (LVPA) Income Statement Analysis – Financial Results
Zymergen Inc. (ZY)
About Zymergen Inc.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
| Metric | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 16.74M | 13.28M | 15.42M |
| Cost of Revenue | 69.72M | 84.82M | 102.64M |
| Gross Profit | -52.98M | -71.53M | -87.22M |
| Gross Profit Ratio | -316.42% | -538.50% | -565.67% |
| Research & Development | 159.12M | 90.85M | 50.72M |
| General & Administrative | 83.01M | 60.08M | 61.25M |
| Selling & Marketing | 23.65M | 18.63M | 24.14M |
| SG&A | 106.66M | 78.70M | 85.39M |
| Other Expenses | 175.51M | 0.00 | 0.00 |
| Operating Expenses | 265.78M | 169.56M | 136.10M |
| Cost & Expenses | 335.50M | 254.37M | 238.74M |
| Interest Income | 64.00K | 492.00K | 4.92M |
| Interest Expense | 14.71M | 10.96M | 2.94M |
| Depreciation & Amortization | 20.70M | 18.71M | 15.20M |
| EBITDA | -326.33M | -232.58M | -218.65M |
| EBITDA Ratio | -1,949.08% | -1,750.80% | -1,418.08% |
| Operating Income | -347.03M | -241.09M | -237.11M |
| Operating Income Ratio | -2,072.68% | -1,814.88% | -1,537.80% |
| Total Other Income/Expenses | -14.71M | -21.15M | 318.00K |
| Income Before Tax | -361.73M | -262.24M | -236.80M |
| Income Before Tax Ratio | -2,160.51% | -1,974.13% | -1,535.74% |
| Income Tax Expense | 51.00K | -49.00K | 8.00K |
| Net Income | -361.79M | -262.19M | -236.80M |
| Net Income Ratio | -2,160.81% | -1,973.76% | -1,535.79% |
| EPS | -4.87 | -2.68 | -2.42 |
| EPS Diluted | -4.87 | -2.68 | -2.42 |
| Weighted Avg Shares Out | 74.31M | 97.94M | 97.94M |
| Weighted Avg Shares Out (Dil) | 74.31M | 97.94M | 97.94M |
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Zymergen Inc. Investors - ZY
Radnor, Pennsylvania--(Newsfile Corp. - October 3, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of lead plaintiff deadline in securities fraud class action lawsuit filed against Zymergen Inc. (NASDAQ: ZY) ("Zymergen") on behalf of...
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Zymergen Inc. Investors - ZY
Radnor, Pennsylvania--(Newsfile Corp. - October 3, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of lead plaintiff deadline in securities fraud class action lawsuit filed against Zymergen Inc. (NASDAQ: ZY) ("Zymergen") on behalf of...
Zymergen Shareholder Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 1, 2021) - Faruqi & Faruqi, LLP, a leading national securities...
Zymergen Shareholder Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 1, 2021) - Faruqi & Faruqi, LLP, a leading national securities...
ZY Investor Alert: Shareholder Lawsuit Deadline Approaching
Boston, Massachusetts--(Newsfile Corp. - October 1, 2021) - The Thornton Law Firm alerts investors who purchased Zymergen Inc. common stock (NASDAQ: ZY) pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial...
ZY Investor Alert: Shareholder Lawsuit Deadline Approaching
Boston, Massachusetts--(Newsfile Corp. - October 1, 2021) - The Thornton Law Firm alerts investors who purchased Zymergen Inc. common stock (NASDAQ: ZY) pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial...
ZY Final Deadline Monday: Rosen, Trusted Investor Counsel, Encourages Zymergen Inc. Investors with Losses in Excess of $100K Secure Counsel Before Important October 4 Deadline in Securities Class Action - ZY
New York, New York--(Newsfile Corp. - October 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively,...
ZY Final Deadline Monday: Rosen, Trusted Investor Counsel, Encourages Zymergen Inc. Investors with Losses in Excess of $100K Secure Counsel Before Important October 4 Deadline in Securities Class Action - ZY
New York, New York--(Newsfile Corp. - October 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively,...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymergen, Inc. - ZY
New York, New York--(Newsfile Corp. - October 1, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Zymergen, Inc. ("Zymergen or the "Company") (NASDAQ: ZY). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymergen, Inc. - ZY
New York, New York--(Newsfile Corp. - October 1, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Zymergen, Inc. ("Zymergen or the "Company") (NASDAQ: ZY). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Source: https://incomestatements.info
Category: Stock Reports